TokenPost·
Ionis Shares Fall 2.23% on Day Roche Publishes Kidney Trial Results
-2.23%
Ionis share drop
Sefaxersen cut proteinuria 43.1% versus placebo at week 37 in adults with primary IgA nephropathy. Ionis shares closed at $42.93 on Oct. 23.
More news
- TokenPostU.S. Stock Futures Fall as Crude Futures Rise in Friday Premarket Trading
- TokenPostVolvo Cars Plans 2,500 Job Cuts in New Cost-Saving Push
- TokenPostBitcoin Falls 3.2% as U.S. ETF Outflows Reach $635 Million
- TokenPostHeineken Warns UK Pubs GLP-1 Drugs Could Pressure Beer Sales
- TokenPostBMT Rises Above $0.039 as Short-Term Gain Exceeds 40%
- TokenPostBMT Briefly Gains More Than 50% During a Sharp Market Move